Hepatitis B Surface Antibody Immunity (Quantitative)
Hepatitis B Surface Antibody Immunity (Quantitative)
This assay is used to determine immune status for Hepatitis B as ≥10 mIU/mL as per CDC Guidelines. Hepatitis B surface antibody quantitation is used to determine hepatitis B immune status, ie, to determine if the patient has developed immunity against the hepatitis B virus. Such immunity may develop following exposure to the hepatitis B virus or its vaccine.
Patients at higher risk of exposure to the virus include:
- Infants born to infected mothers
- Sex partners of infected persons
- People with more than 1 sex partner in the last 6 months
- People with a history of sexually transmitted infection
- Men who have sex with men
- Injection drug users
- Household contacts of an infected person
- Healthcare and safety workers who have contact with blood and body fluids
- People who have lived or traveled in an area in which hepatitis B is common
- People who live or work in a prison
Testing is not recommended routinely following vaccination. It is advised only for people whose subsequent clinical management depends on knowledge of their immune status. These people include:
- Chronic hemodialysis patients
- Immunocompromised people, including those with HIV infection, hematopoietic stem-cell transplant recipients, and people receiving chemotherapy
- Infants born to women who test positive for the hepatitis B surface antigen
- Sex partners of people who test positive for the hepatitis B surface antigen
- Healthcare and public safety workers who have contact with blood or body fluids
Hepatitis B Surface Antibody Immunity (Quantitative)
$31
Average competitors price$99
Pricing based on average direct to consumer pricing.- WHAT IT TESTS: For the presence of hepatitis B antibody.
- WHY TAKE IT: Determine if you are immune to hepatitis B.
- REQUIRES FAST? No.